Skip to main content
Caplight Logo









Cheiron

Cheiron

Private
United StatesHealthcare & Life Scienceshttps://www.cheiron.bio/

Last Round

Seed

Jul 22, 2026

Total Funding Raised

$4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Cheiron operates in Healthcare & Life Sciences and is based in the United States. Its latest recorded funding round was a Seed round in August 2025.

Cheiron is a software company that provides an AI-powered operating system for biopharma teams to manage drug program evidence, research, and regulatory workflows.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Workflow Automation, Compliance & Risk

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Cheiron Comparables

Compare Cheiron with similar companies based on industry and business-model similarity.

Cheiron comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Convoke
92%
Artos
82%
AlphaLife Sciences
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Cheiron Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 22, 2026
SeedAug 4, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Cheiron Investors

Notable investors and investment history

Cheiron investors
InvestorRounds
Menlo VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 22, 2026

    $8M round led by Menlo Ventures

  • Aug 4, 2025

    Raised $4M with SK Networks leading the round.

Book a demo to see all signals

For institutional investors. Book with your work email.

Cheiron Filings

Explore SEC and related filing metadata, where available.

Cheiron filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Cheiron's valuation, stock price, and market status.

Is Cheiron a public or private company?

Cheiron is a private company.

What is the current stock price of Cheiron?

Cheiron is a private company, so its shares have no public market price. Caplight tracks Cheiron's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cheiron worth (valuation)?

Valuation information for Cheiron is not publicly available.

Can I buy Cheiron stock?

Cheiron shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cheiron's last funding round?

Cheiron's most recent funding round was Seed on July 22, 2026.

Who are the main investors in Cheiron?

Key investors in Cheiron include Menlo Ventures.

Will Cheiron IPO soon?

No public IPO plans have been announced for Cheiron.

How can I track Cheiron secondary market activity?

Caplight tracks bids, offers, and trades in Cheiron's shares on secondary markets.

Firmographic Details

HeadquartersUnited States
Year Founded2024
Last FundingJul 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?